AUG 12, 2026 · PHASE 2 TRIAL
A Study to Evaluate the Safety and Biomarker Effects of RO7269162 in Participants at Risk for or at the Prodromal Stage of Alzheimer's Disease (AD)
ClinicalTrials.gov
This is an active Phase 2 trial registration with no results posted; the evidence base is the study design and planned endpoints only, not clinical outcomes.
Reported
Planned enrollment256
Study phasePhase 2
Primary endpoint 1Incidence of adverse events (AEs), up to we…